In-N-Out Burger forced to change its menu after RFK's new rule
The West Coast-based burger chain will be changing the recipe used to create its popular strawberry shake and signature pink lemonade in order to remove the red dye No. 40 in the drinks.
In-N-Out also revealed that it would be making changes to its ketchup, and switching out the ingredient, high fructose corn syrup, for real sugar.
According to a statement, In-N-Out Owner and President Lynsi Snyder shared with Newsweek, the red dye will be replaced with beta carotene and vegetable juice.
'We've additionally introduced a healthier beverage sweetener option by replacing sucralose and saccharin sweetener packets with Stevia Leaf Extract, and added a non-dairy alternative, oat milk creamer,' she told the publication. 'We're also in the process of transitioning to ketchup made with real sugar instead of high fructose corn syrup, and researching an even better-quality oil for our fries.'
The burger chain has become one of the first fast-food chains to start shifting away from using petroleum-based synthetic dyes since the HHS and FDA made the announcement last month.
The Trump administration said the move to eliminate synthetic dyes from the food supply by the end of next year could mark a 'major step forward' in the drive to 'Make America Healthy Again.' The ban would impact products such as breakfast cereals, candy and snacks. The dyes have been tied to neurological problems in some children.
'For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent,' Kennedy said in a statement at the time. 'These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and development.'
He added: 'We're restoring gold-standard science, applying common sense, and beginning to earn back the public's trust. And, we're doing it by working with industry to get these toxic dyes out of the foods our families eat every day.'
At a cabinet meeting at the beginning of April, Kennedy claimed the dyes directly affect 'academic performance, violence in the schools, and mental health, as well as physical health.'
The department said the FDA is fast-tracking the review of natural alternatives to synthetic dyes and that its agency is taking steps to issue guidance and provide regulatory flexibilities to industries.
'We have a new epidemic of childhood diabetes, obesity, depression, and ADHD,' FDA Commissioner Dr. Marty Makary said during the initial announcement. 'Given the growing concerns of doctors and parents about the potential role of petroleum-based food dyes, we should not be taking risks and do everything possible to safeguard the health of our children.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
EPA puts on leave 139 employees who spoke out against policies under Trump
The Environmental Protection Agency on Thursday put on administrative leave 139 employees who signed a 'declaration of dissent' with its policies, accusing them of 'unlawfully undermining' the Trump administration's agenda. In a letter made public Monday, the employees wrote that the agency is no longer living up to its mission to protect human health and the environment. The letter represented rare public criticism from agency employees who knew they could face blowback for speaking out against a weakening of funding and federal support for climate, environmental and health science. In a statement Thursday, the EPA said it has a 'zero-tolerance policy for career bureaucrats unlawfully undermining, sabotaging and undercutting' the Trump administration's agenda. Employees were notified that they had been placed in a 'temporary, non-duty, paid status' for the next two weeks, pending an 'administrative investigation,' according to a copy of the email obtained by The Associated Press. 'It is important that you understand that this is not a disciplinary action,' the email read. More than 170 EPA employees put their names to the document, with about 100 more signing anonymously out of fear of retaliation, according to Jeremy Berg, a former editor-in-chief of Science magazine who is not an EPA employee but was among non-EPA scientists or academics to also sign. Scientists at the National Institutes of Health made a similar move in June, when nearly 100 employees signed a declaration that assailed Trump administration 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' An additional 250 of their colleagues endorsed the declaration without using their names. But no one at NIH has been placed on administrative leave for signing the declaration and there has been no known retribution against them, Jenna Norton, a lead organizer of the statement, told AP on Thursday. Norton oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases. NIH Director Jay Bhattacharya, in his confirmation hearings, had pledged openness to views that might conflict with his own, saying dissent is the 'essence of science.' Under Administrator Lee Zeldin, EPA has cut funding for environmental improvements in minority communities, vowed to roll back federal regulations that lower air pollution in national parks and tribal reservations, wants to undo a ban on a type of asbestos and proposed repealing rules that limit planet-warming greenhouse gas emissions from power plants fueled by coal and natural gas. Zeldin began reorganizing the EPA's research and development office as part of his push to slash its budget and gut its study of climate change and environmental justice. And he's seeking to roll back pollution rules that an AP examination found were estimated to save 30,000 lives and $275 billion every year. The EPA responded to the employees' letter earlier this week by saying policy decisions 'are a result of a process where Administrator Zeldin is briefed on the latest research and science by EPA's career professionals, and the vast majority who are consummate professionals who take pride in the work this agency does day in and day out.' ___
Yahoo
3 hours ago
- Yahoo
Theratechnologies shares surge 25% amid $254m Future Pak takeover
Contract manufacturer Future Pak will acquire Theratechnologies in a $254m deal, bringing an end to a drawn-out sale process of the Canadian HIV-specialist biopharma. Via its affiliate CB Biotechnology, US-headquartered Future Pak will purchase shares in Theratechnologies for $3.01 each plus a contingent value right (CVR) of $1.19 on the achievement of future milestones. Shares in Theratechnologies increased 25% at market open following the takeover announcement. The drugmaker has a market cap of $144.6m. The transaction, which will bring the currently Nasdaq-listed Theratechnologies back under private ownership, means Future Pak is paying a cash premium of 126% on the last closing share price for the biopharma. Theratechnologies has two products in the HIV arena that are approved by the US Food and Drug Administration (FDA), namely Egrifta (tesamorelin F8) and Trogarzo (ibalizumab-uiyk). Egrifta is approved to reduce excess visceral abdominal fat in adults with HIV and lipodystrophy while Trogarzo is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistance. Egrifta WR took over from Egrifta SV in March 2025, offering a more convenient formulation. Expected to close in Q4, the deal will close a sale process that has fluctuated over the past year. Future Pak's first attempt to acquire Theratechnologies was rebuffed in August 2024, with the biopharma deeming the $100m offer too low. Future Pak returned to the deal table in January 2025. Theratechnologies had already entered an exclusivity agreement with another potential acquirer, meaning Future Pak was once again turned away. Theratechnologies eventually opened the sale process to other parties, opening the door for a potential deal with the contract manufacturer. In April 2025, Future Pak tabled a $255 offer, which has now been accepted by the drugmaker. Theratechnologies reported 2024 revenue of $85.9m, a 5% increase from the $81.8m accumulated in 2023. Whilst the company reported a positive EBITDA for the year, it struggled with supply for Egrifta WR due to an issue with a contract manufacturer. Still, sales of the drug grew 12%, unlike Trogarzo, which dropped 8% due to 'competitive pressures' in the multidrug-resistant segment of the HIV market. 'This transaction is the result of a thorough and deliberate sale process aimed at maximising value for our shareholders,' stated Frank Holler, Theratechnologies' chair of the board of directors. 'Future Pak's interest in acquiring Theratechnologies represents a vote of confidence in the company we've built, recognising our achievements in bringing innovative medicines to patients and the outstanding contributions of our dedicated employees.' Last year, Future Pak also made multiple unsuccessful attempts to acquire Vanda Pharmaceuticals, the developer of sleep disorder drug Hetlioz. Cycle Therapeutics ultimately won out, acquiring in a $466m deal. "Theratechnologies shares surge 25% amid $254m Future Pak takeover" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
3 hours ago
- Business Upturn
Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability
Chicago, July 03, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction: Reframing Fall Risk in Aging Populations Across the United States, fall-related injuries continue to be a top health concern among older adults. Data from the CDC reveals that one in four Americans aged 65+ experiences a fall each year, with over 800,000 requiring hospitalization. While often attributed to aging, recent biomechanical research highlights deeper underlying causes, including diminished sensory feedback from the feet—an overlooked but significant contributor to instability. With the search for safe, sustainable interventions intensifying, non-invasive options that align with lifestyle accessibility and neuroscience are drawing increased interest. The emergence of nerve-centric balance theories has led to a shift in how wellness providers approach fall prevention. Rather than relying solely on strength-based rehabilitation, newer approaches focus on restoring proprioceptive communication—how the body senses ground contact and responds reflexively to prevent imbalance. These trends are shaping consumer expectations around what it means to stay mobile, strong, and independent while aging. Neuro Balance Therapy is among the programs aiming to meet this demand with targeted, at-home methods based on new understandings of nerve-muscle coordination. To access the full program details and review the educational material, visit the official platform. Section 2 – Neuro Balance Therapy Program Update: Evolution of a Non-Clinical Stability Protocol In alignment with ongoing demand for at-home balance strategies, Neuro Balance Therapy has released a 2025 update to its protocol, reinforcing its educational foundation in proprioceptive activation and nerve-response science. Developed by Certified Balance Specialist Chris Wilson, the program continues to provide structured instruction centered around the stimulation of the deep peroneal nerve —a sensory-motor pathway shown in academic studies to play a critical role in foot reflexes and muscular coordination. Unlike strength-based fitness plans or conventional physiotherapy sessions, Neuro Balance Therapy centers on a simple, time-efficient daily ritual that requires no gym equipment, medication, or clinical oversight. This protocol uses a proprietary 'nerve wake-up' ball designed to apply patterned pressure across the plantar surface of the foot to help retrain dormant nerve endings that contribute to instability. The 2025 update maintains its original DVD format with guided video sequences segmented by progression level—beginner, intermediate, and advanced—while also offering a digital option for increased accessibility. The program is particularly tailored for adults over 60 who may experience heightened fear of falling, previous fall incidents, or early signs of reduced mobility. Program developer Wilson highlights that this expanded reach reflects an effort to ensure that aging adults have a reliable, educational tool to build confidence in movement. Neuro Balance Therapy remains grounded in a non-diagnostic framework and is presented as a supportive lifestyle enhancement based on emerging research in neuromechanics and gerontology. Section 3 – Trend Analysis: Public Concerns, Fall Anxiety, and Rising Interest in Home-Based Prevention Fall prevention has become one of the most searched-for health concerns among adults over 60, particularly those living independently or recovering from injury. A growing body of online discussions reveals a pattern of fear, hesitation, and uncertainty among older individuals—especially those who have experienced falls in the past or live with limited mobility. This trend is reflected not only in medical safety forums and caregiver blogs but also in keyword search data indicating a spike in interest around terms like 'fall-proof exercises,' 'senior balance support,' and 'home remedies for stability.' As mobility-related anxiety grows, consumers are increasingly looking for evidence-based yet low-barrier solutions that can be adopted from home. Rather than focusing solely on strength or endurance, public attention has turned to neuromuscular control—specifically the role of reflexive foot response in preventing unintentional falls. Individuals researching fall risk reduction now frequently encounter terms like 'proprioception,' 'nerve activation,' and 'sensorimotor training' as part of this broader narrative shift. Within this climate of heightened concern and education-seeking behavior, Neuro Balance Therapy has attracted attention for its practical alignment with these needs. Its core premise—that reawakening a dormant foot nerve can reengage natural reflexes and increase stability—reflects the growing interest in nervous system-focused approaches that move beyond traditional exercise or strength-building routines. While not positioned as a replacement for clinical care, the protocol meets a gap in the market where education, self-reliance, and routine movement rituals converge. Further information, including transparency disclosures and instructional methodology, is available through the authorized distribution channel. Section 4 – Spotlight on Proprioceptive Tools and Neuromuscular Activation At the core of the Neuro Balance Therapy protocol is a targeted tool: a specialized spiked ball engineered to stimulate sensory receptors along the sole of the foot. While deceptively simple in appearance, the design is based on emerging studies around tactile feedback and the role of deep nerves in foot stability. The tool is used in a brief 10-second morning ritual to activate what researchers identify as the deep peroneal nerve , which plays a critical role in reflexively engaging foot and lower leg muscles when movement begins or imbalance occurs. The textured surface of the ball is constructed with hardened crystalline polymers—chosen for their ability to provide a consistent, non-compressive stimulus during rolling motions. This form of physical input has been shown in third-party studies to support the re-engagement of sensory-motor pathways that often degrade with age, shoe use, or injury recovery. Rather than functioning as an exercise device, the tool acts as a proprioceptive primer—a method to help the body regain contact awareness with the ground and reestablish neuromuscular timing. This approach draws on insights from evolutionary biomechanics and comparative anthropology, such as those observed in populations accustomed to barefoot mobility. Researchers from Harvard and other institutions have noted that such individuals tend to exhibit stronger foot-ground sensory feedback and lower fall risk later in life—attributed not to strength but to continuous nerve engagement over time. While Neuro Balance Therapy does not claim to treat or diagnose any condition, the inclusion of this tactile tool is aligned with broader wellness trends that seek to improve functional confidence through non-invasive, neuro-supportive interventions. The emphasis on activating rather than strengthening mirrors a shift in how consumers and wellness educators approach stability challenges—one rooted in nervous system health rather than musculoskeletal strain. Section 5 – User Journey Narrative and Market Reception Ongoing online dialogue reveals a clear and consistent theme among older adults concerned with fall-related limitations: the emotional toll of instability often surpasses the physical impact. Reports across support forums and aging wellness platforms reflect a growing frustration with traditional mobility solutions that feel either inaccessible or incomplete. Many express the desire to feel 'safe in their own homes' or to reclaim confidence performing routine tasks without the looming anxiety of a fall. Within this discourse, Neuro Balance Therapy has emerged as a topic of interest, particularly among individuals seeking alternatives to large-scale physical therapy programs or invasive medical options. While individual testimonials are not cited in public releases for compliance reasons, general sentiment within the community has centered on the appeal of the program's simplicity, home-based accessibility, and the perceived novelty of targeting a sensory nerve often overlooked in standard fall prevention plans. The narrative tone of market discussions is often one of cautious optimism. Some describe past experiences with balance training programs that required gym access, heavy equipment, or high mobility thresholds—barriers that left many behind. In contrast, Neuro Balance Therapy is often mentioned as an entry-point protocol: a minimal-commitment routine that offers a sense of daily empowerment and a framework for understanding how balance and stability can be proactively supported without intensive oversight. This emotional connection—between fear, autonomy, and confidence—continues to shape the public reception of fall-prevention solutions. Neuro Balance Therapy's alignment with those concerns, coupled with its non-intimidating delivery format, has contributed to its sustained visibility among aging communities, wellness bloggers, and caregiving resource hubs. Section 6 – Availability and Transparency Statement The complete Neuro Balance Therapy program is currently accessible through the brand's official platform, where consumers can review educational materials and explore the science-backed methodology behind the protocol. The program is offered in both physical and digital formats to accommodate varying technology preferences and household setups. Each version includes access to guided instructional content and the proprietary nerve activation tool central to the protocol's design. All educational content within the program is intended strictly for informational purposes and is presented as a non-clinical, home-based resource. Neuro Balance Therapy does not diagnose or treat medical conditions, and individuals are advised to consult with their healthcare provider before beginning any new wellness regimen. Program components are designed to complement, not replace, broader wellness or physical rehabilitation efforts and are delivered in alignment with current best practices in consumer safety and instructional clarity. Further product details, background information, and transparency disclosures can be found on the official program website. Information about program structure, availability, and research alignment can be found at the official access site. Section 7 – Final Observations and Industry Context The current landscape of fall-prevention solutions reveals an evolving market shaped by demographic trends and wellness consumer expectations. As the population over 60 continues to expand, so does the need for preventative strategies that prioritize accessibility, non-invasiveness, and autonomy. With falls now recognized by public health institutions as both a clinical and lifestyle issue, there is increased scrutiny on programs that promise safety without sustainable, evidence-informed frameworks. Neuro Balance Therapy enters this environment with a measured approach—framing fall prevention not as a fitness goal, but as a daily practice of neurosensory engagement. Its emphasis on proprioceptive restoration, combined with an at-home format, reflects growing demand for solutions that bridge the gap between clinical rehabilitation and consumer-directed wellness. As the industry moves toward greater personalization in health routines, protocols that integrate functional simplicity with research-inspired insights are likely to gain traction. This update also underscores a wider trend: the reframing of mobility and balance not as age-related inevitabilities, but as skillsets that can be reinforced through nerve and muscle coordination. While more longitudinal research is warranted, early public interest in such targeted tools suggests a shift away from generalized exercise programs toward precision-oriented interventions. As balance science continues to develop, Neuro Balance Therapy positions itself as part of the broader movement redefining how older adults interact with their own mobility—through agency, awareness, and the reawakening of long-dormant neuromechanical responses. Section 8 – Public Commentary Theme Summary: Risk Awareness, Independence, and Program Accessibility Public conversations surrounding fall prevention continue to reveal a wide spectrum of experiences and emotions—ranging from fear and frustration to empowerment and cautious hope. A recurring discussion point in online forums and wellness communities is the fear of losing independence due to instability or past fall incidents. Many express concern over the limitations of traditional mobility programs, which often require clinical oversight, frequent appointments, or physical exertion that can feel overwhelming for individuals with existing discomfort or restricted movement. Some have noted the appeal of Neuro Balance Therapy for its non-strenuous routine and minimal space requirements. The fact that the program can be done while seated—without the need for specialized shoes, physical therapy appointments, or weight-bearing movement—has drawn interest among those recovering from injury or living alone. Skepticism also surfaces in certain segments of the discussion. A common question centers on whether a simple nerve-activation ritual could truly make a difference, particularly when contrasted with more robust physical therapy approaches. Others express concern over the proliferation of at-home solutions that appear promising but offer limited scientific transparency. However, the continued referencing of supporting studies on proprioception and deep nerve reflexes helps validate consumer interest and aligns with a trend toward self-education in aging wellness. Overall, public commentary reflects a desire for straightforward, low-barrier entry points into fall-prevention that emphasize autonomy, emotional reassurance, and ease of use. Neuro Balance Therapy's positioning within that dialogue—especially as it avoids over-promising outcomes—has enabled it to retain credibility while encouraging broader conversations about sensory-motor awareness as a foundation for lifelong mobility. About the Company Neuro Balance Therapy is a wellness education program founded with the goal of supporting older adults in regaining stability, confidence, and ease of movement through non-clinical, home-based strategies. Established by Certified Balance Specialist Chris Wilson, the program draws on over a decade of experience in balance instruction and proprioceptive training. Rooted in research-backed methods, Neuro Balance Therapy offers instructional tools designed to help activate underutilized sensory nerves responsible for lower-body coordination. The company's approach reflects a broader commitment to empowering individuals through accessible routines that promote physical self-reliance. Neuro Balance Therapy does not provide treatment or diagnostic services and encourages all users to consult their healthcare provider before beginning any new movement or balance routine. Contact Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
